19 June 2013
Keywords: expanded, indication, pfizer, aromasin, drugs, giant, says
Article | 19 September 2005
Drugs giant Pfizer says that its aromatase inhibitor Aromasin (exemestane) can now be prescribed to postmenopausal women with early
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
19 September 2005
18 June 2013
© 2013 thepharmaletter.com